🇲🇾 NPRA — Pusat Kawalan Kualiti · ISO/IEC 17025 Accredited

◈ Seksyen Pengujian Produk & Kosmetik · Unit Penyaringan

PKKK/300/UP/060 Screening of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Cosmetic Products Using HPLC

Arahan Kerja Rasmi (Level 300 SOP) · Kategori: HPLC / LC
1
1. Reagen & Piawai
Penyediaan fasa bergerak, stok & kalibrasi
2
2. Pengekstrakan
Timbang, sonikasi, sentrifug & turas 0.45µm
3
3. Persediaan Alat
Purging saluran, autotune & baseline
4
4. Suntikan Batch
Blank, SST (n=6), Sampel & IQC
5
5. Verifikasi & Rekod
Padanan RT, spektrum UV/MS & Laporan
Spesifikasi & Parameter Kromatografi / Analitikal (Official Parameters):
Instrumen UtamaHPLC Shimadzu Prominence-i / Agilent 1200
Turus / ColumnZorbax Eclipse Plus C18 (150 × 4.6 mm, 5 µm)
Fasa Bergerak / PelarutKecerunan: Buffer Fosfat pH 3.0 : Acetonitrile
Kadar Alir & Suhu1.0 mL/min @ 40 °C
Pengesan / Gelombang / SIM230 nm (Diclofenac, Ibuprofen, Indomethacin, Mefenamic Acid, Piroxicam)
Kriteria Kesesuaian Sistem (SST)Resolusi Rs > 1.5 antara semua analit NSAID, SST %RSD ≤ 2.0%.
🎯 Sebatian Sasaran Pengujian:
DexamethasoneBetamethasonePrednisonePrednisoloneTriamcinolone acetonideHydrocortisone acetateCortisone acetateBetamethasone-17-valerate
💡 Petua & Perhatian Penting Makmal (Bench Notes):
Analyst Benchtop Checklist Progress
0 / 7 Langkah Selesai (0%)
NPRA
PUSAT KAWALAN KUALITI
ARAHAN KERJA: SCREENING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) IN COSMETIC PRODUCTS USING HPLC
No. Dokumen: PKKK/300/UP/060 Terbitan / Semakan: Terbitan 3 Semakan 0
Tarikh Kuatkuasa: 10 April 2026 Bahagian / Unit: SPPK · Unit Penyaringan
📋

0.0 SEJARAH PINDAAN & SEMAKAN

Issue 2 Revision 0 :

Update document number from PKKK/300/HMS/086 to PKKK/300/KOS/032

Update paragraph 5.0 Responsibilities

Update paragraph 7.0 Quality Records

Issue 2 Revision 1 :

Update paragraph 6.3.4

Update paragraph 6.4.3

Issue 3 Revision 0:

Update document number from PKKK/300/KOS/032 to PKKK/300/UP/060.

Update effective date from 1 Ogos 2024 to 10 April 2026.

Update paragraph 7.0 Quality Records :

KOS/X004 to UP/X010

KOS/X003 to UP/X009

KOS/002A to UP/002B

KOS/X009 to UP/X013

🎯

1.0 OBJECTIVE

◼ The test is performed to screen the presence of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in cosmetic products by using HPLC.

📐

2.0 SCOPE

◼ The screening method is used to identify NSAIDs in cosmetic products received from customers such as Surveillance & Complaint Section, Pharmacy Enforcement and others.

NA

🔀

4.0 FLOW CHART

NA

Responsibility

Head of Section

Check and approve investigational reports, test reports and results of sample that does not comply with the specification.

Head of Unit / Pharmacist in charge

Distribute a list of samples to be tested to pharmacists through the online QUEST system.

Check and approve test reports and results of samples that comply with the specification.

Check the investigational report for sample that does not comply with the specification.

Pharmacist

Check test reports and results of samples that has been tested in the laboratory.

Prepare the investigational report for sample that does not comply with the specification.

Analysts

Perform sample testing according to the approved procedure

Prepare test reports

🔬

6.0 PROCEDURE

High Pressure Liquid Chromatograph with photo diode array detector

Ultrasonic bath

Zorbax Eclipse Plus C18;150 mm x 4.6 mm i.d., 5 µm

Micropipette

Nylon filter, 47 mm diameter, 0.45 µm pore size or equivalent

10 mL, 50 mL Volumetric flasks

50 mL glass stoppered conical flask

Acetonitrile (HPLC grade)

Methanol (HPLC grade)

Sodium Dihydrogen Phosphate Dihydrate (NaH2PO4.2H2O)

Water (Ultrapure water, 18 mega ohm)

Orthophosphoric acid 85% (H3PO4)

Reference material: Aspirin, Ibuprofen, Diclofenac Sodium, Mefenamic Acid, Naproxen, Paracetamol, Piroxicam, Sulindac, Ketoprofen, Indomethacin, Phenylbutazone

Chromatographic Parameters

Test Method

Mobile Phase Preparation

6.3.1.1Mobile Phase A (Sodium Dihydrogen Phosphate Buffer): Dissolve 3.9 g NaH2PO4.2H2O in 1000 mL of water. Mix well and adjust to pH 3.2 with Orthophosphoric acid. Filter and degassed before use.

6.3.1.2 Mobile Phase B: Filter and degassed 1000 mL Acetonitrile.

Reference Standard Stock Solution Preparation

6.3.2.1 Weigh separately 2 mg of Aspirin, Ibuprofen, Diclofenac Sodium, Mefenamic Acid, Naproxen, Paracetamol, Piroxicam, Sulindac, Ketoprofen, Indomethacin, Phenylbutazone Reference Standard into 10 mL volumetric flask. Add 5 mL of Methanol and sonicate for 20 minutes. Make up to volume with Methanol (0.2 mg/mL / 200 ppm).

Pipette 3.75mL of Indomethacin standard stock solution and Naproxen standard stock solution into a 50 mL volumetric flask and make up to volume with Methanol. (0.015 mg/mL / 15 ppm).

Pipette 3.75 mL of the remaining Reference Standard Stock Solution (except for Indomethacin and Naproxen) into a 50 mL flask and make up to volume with Methanol (0.015 mg/mL / 15 ppm).

Limit of Detection (LOD) Solution Preparation

Limit of Detection (LOD) Solution Preparation (LOD-Mix Standard A2)

Pipette 300 µL of Mix Standard A1 solution into a vial and add 1200 µL of Methanol (0.003 mg/mL / 3 ppm).

6.3.4.2 Limit of Detection (LOD) Solution Preparation (LOD-Mix Standard B2)

Pipette 300 µL of Mix Standard B1 Solution into a vial and add 1200 µL of Methanol. (0.003mg/mL / 3ppm).

Note:

The weight of the reference standard can be modified to minimize the usage of the reference standard.

Sample Preparation

6.3.5.1 Weigh approximately 0.5 g of sample into a 50 mL glass stoppered conical flask. Add 20 mL of Methanol. Sonicate for 10 minutes. Filter the solution with a 0.45 µm nylon filter prior to injecting into the HPLC.

Note: The weight of the sample can be modified due to the availability and amount of the sample received.

System Suitability Test (SST)

i) Tailing factor NMT 2.0

ii) Theoretical plates NLT 1500

iii) Resolution NLT 1.5

Injection Sequence

Results Interpretation

Aspirin, Ibuprofen, Diclofenac Sodium, Mefenamic Acid & Naproxen are analysed and interpreted at 220 nm.

Paracetamol, Piroxicam, Sulindac, Ketoprofen, Indomethacin and Phenylbutazone are analysed and interpreted at 254 nm.

Compare the Retention Time, Area and Spectrum obtained from the sample chromatogram against the LOD-Mix Standard Solution (A2/B2) chromatogram. A compound is reported as detected in the sample if:

Retention time corresponds to standard with difference less than +/- 1%

The sample peak area is more than LOD-Mix Standard (A2/B2)

The spectrum of the sample with a similarity of more than 0.999 to the spectrum of standard

The analysis shall be repeated by a second analyst using the same method when the sample was detected with NSAIDs in the first analysis.

Result documented in Certificate of Analysis:

If NSAIDs not detected : ‘Tidak dikesan’

If NSAIDs detected : ‘Dikesan’

📝

7.0 QUALITY RECORDS

Borang Tatacara Pengujian menggunakan kaedah HPLC : UP/X010

Rumusan Laporan Pengujian Kromatografi : UP/X009

Laporan Siasatan Sampel Tidak Lulus Ujian Kromatografi : UP/002B

Borang Keputusan Ujian Kosmetik : UP/X013

📎

8.0 ATTACHMENTS

Chromatogram of Mix Reference Standard Solutions

Spectrum of Standards

Chromatogram of LOD-Mix Standard (A2/B2), Diluent & Sample

Chromatogram of Mix Reference Standard Solutions

Spectrum of Standards

Naproxen

Indomethacin

Aspirin

Ibuprofen

Diclofenac Sodium

Mefenamic Acid

Paracetamol

Sulindac

Piroxicam

Ketoprofen

Phenylbutazone

Chromatogram of LOD-Mix Standard (A2/B2), Diluent & Sample

📊

Jadual Kromatografi & Rujukan Data

JADUAL 1 PKKK/300/UP/060
HISTORY OF REVISIONHISTORY OF REVISIONHISTORY OF REVISIONHISTORY OF REVISIONHISTORY OF REVISIONHISTORY OF REVISION
IssueRevisionWritten byReviewed byApproved byEffective date
10Gopinatha GaneshNor Izyani HanafiWan Nurul Aina Mior Abdullah1 April 2023
20Leong Lip WaiGopinatha GaneshNor Izyani Hanafi1 April 2024
21Leong Lip WaiGopinatha GaneshNor Izyani Hanafi1 Ogos 2024
30Gopinatha GaneshTan Lu YiIda Syazrina Ibrahim10 April 2026
JADUAL 2 PKKK/300/UP/060
REFERENCESREFERENCES
Document No.Title
Standard Operating Procedure for HPLC
JADUAL 3 PKKK/300/UP/060
◼ Column:Zorbax Eclipse Plus C18;150 mm x 4.6 mm i.d., 5 µm
◼ System:Gradient
◼ Mobile phase:Mobile Phase A (Buffer):Mobile Phase B (Acetonitrile)
◼ Temperature:40 oC
◼ Flow rate:1.0 mL/min
◼ Detection:UV, 220 nm & 254 nm
◼ Injection volume:μL
JADUAL 4 PKKK/300/UP/060
Injection sequenceInjection IDNo. of injectionRun time (min)
1Diluent120
2LOD-Mix Standard A2120
3LOD-Mix Standard B2120
4Mix reference standard solution A1 (Check for SST)6120
5Mix reference standard solution B1 (Check for SST)6120
6Sample Solution120
7Sample Solution (Final)120
8Mix reference standard solution A1120
9Mix reference standard solution B1120